BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19215011)

  • 1. Essential thrombocythemia: a case of acute ST-segment elevation myocardial infarction in a young female.
    Bildirici U; Celikyurt U; Ural E
    Clin Cardiol; 2009 Feb; 32(2):104-5. PubMed ID: 19215011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute coronary syndromes: an update. I. Pathogenesis and drug therapy].
    Auer J; Berent R; Maurer E; Mayr H; Weber T; Eber B
    Herz; 2001 Mar; 26(2):99-110. PubMed ID: 11349620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
    N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor.
    Gül C; Kürüm T; Demir M; Ozbay G; Vural O; Iqbal O; Fareed J
    Clin Appl Thromb Hemost; 2004 Jan; 10(1):77-9. PubMed ID: 14979411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
    Blazing MA; de Lemos JA; White HD; Fox KA; Verheugt FW; Ardissino D; DiBattiste PM; Palmisano J; Bilheimer DW; Snapinn SM; Ramsey KE; Gardner LH; Hasselblad V; Pfeffer MA; Lewis EF; Braunwald E; Califf RM;
    JAMA; 2004 Jul; 292(1):55-64. PubMed ID: 15238591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.
    Hermanides RS; Ottervanger JP; ten Berg JM; Gosselink AT; van Houwelingen G; Dambrink JH; Stella PR; Hamm C; van 't Hof AW;
    J Invasive Cardiol; 2012 Mar; 24(3):84-9. PubMed ID: 22388296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis?
    Ibrahim K; Hass N; Kolschmann S; Strasser RH; Braun-Dullaeus RC
    Clin Res Cardiol; 2008 Nov; 97(11):797-800. PubMed ID: 18663507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombotic treatment of acute coronary syndromes without ST-segment elevation].
    Radke PW; Schunkert H
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S204-7. PubMed ID: 17109249
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
    Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
    N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive therapies in the cath lab. Combination of tirofiban and alteplase in acute myocardial infarction.
    Arjomand H; Sokil AB; Arjmand R; Fischer HA; Wolf NM
    J Invasive Cardiol; 2001 Sep; 13(9):647-50. PubMed ID: 11533504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty.
    Uyarel H; Uzunlar B; Unal Dayi S; Tartan Z; Samur H; Kasikcioglu H; Akgul O; Simsek D; Erdem I; Okmen E; Cam N
    Cardiology; 2006; 105(3):168-75. PubMed ID: 16479104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential thrombocythemia-related acute ST-segment elevation myocardial infarction. A case report and literature review.
    Daya SK; Gowda RM; Landis WA; Khan IA
    Angiology; 2004; 55(3):319-23. PubMed ID: 15156266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Absence of benefit with triple antiaggregation in acute non persistent ST segment elevation myocardial infarction in patients not subjected to early interventionism].
    Blancas Gómez-Casero R; Nevado Losada E; López Matamala B; Martínez Díaz C; Serrano Castañeda J; Yáñez Parareda E; González Manzanares JL; Chana García M; Martín Delgado C
    Med Intensiva; 2007 May; 31(4):165-71. PubMed ID: 17562300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
    Okmen E; Cakmak M; Tartan Z; Cam N
    Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exercise-induced left arm pain and thrombocytosis].
    Kunz I; Spada S; Sütsch G; Ruggieri F
    Praxis (Bern 1994); 2005 Apr; 94(15):599-603. PubMed ID: 15884726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antithrombotic therapy during percutaneous coronary interventions].
    Verheugt FW; Dieker H; Aengevaeren WR
    Ned Tijdschr Geneeskd; 2005 Apr; 149(17):912-6. PubMed ID: 15884403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of life-saving pharmacologic and mechanical coronary dethrombosis.
    Colombo A; Danna P; Piccaluga E; Viecca M
    Ital Heart J; 2004 Nov; 5(11):864-8. PubMed ID: 15633443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction.
    Bosch X; Marrugat J
    Cochrane Database Syst Rev; 2001; (4):CD002130. PubMed ID: 11687143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.
    Armstrong PW;
    Eur Heart J; 2006 Jul; 27(13):1530-8. PubMed ID: 16757491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.